Opko Health Presents Additional Data On RAYALDEE At National Kidney Foundation Spring Clinical Meetings 2016
MIAMI--(BUSINESS WIRE)--OPKO Health, Inc. (NYSE:OPK), announced that additional data on RAYALDEE as a treatment for secondary hyperparathyroidism (SHPT) will be highlighted later today in a poster presentation at the National Kidney Foundation Spring Clinical Meetings, underway in Boston, MA.